Bicara Therapeutics Inc. · NASDAQ:BCAX
Deep Track Capital, LP reported a 5.02% stake in Bicara Therapeutics Inc. (Schedule 13G)
Event Feb 5, 2026 · Filed Feb 12, 2026
Deep Track Capital, LP reported a 5.02% stake in Bicara Therapeutics Inc., 2,750,000 shares, as a passive investor on Feb 5, 2026. Filed Feb 12, 2026 (Schedule 13G).
- Stake
- 5.02%
- Shares
- 2,750,000
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Deep Track Capital, LP | 5.02% | 2,750,000 |
| Deep Track Biotechnology Master Fund, Ltd. | 5.02% | 2,750,000 |
| David Kroin | 5.02% | 2,750,000 |
Source
Related
- Bicara Therapeutics Inc.
- Deep Track Capital, LP
- Bicara Therapeutics Inc. shareholders
- Schedule 13G/A · Deep Track Capital, LP · May 15, 2026
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Oct 7, 2026
- Form 4 · Cohlhepp Ryan · Sep 10, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Aug 13, 2026
- Form 4 · Hyep Ivan · Aug 12, 2026
- Form 4 · Mazumdar Claire · Aug 12, 2026